New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from Pseudomonas aeruginosa contaminated dialysate

Blood Purification

Volumn 16, Issue 4, 1998, Pages 210-219

  Jaber, Bertrand L ^a   Gonski, Julie A ^a   Cendoroglo, Miguel ^a   Balakrishnan, V S ^a   Razeghi, Peter ^b   Dinarello, Charles A ^b   Pereira, Brian J G ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Biocompatibility; Hemodialysis; Interleukin 6; Interleukin 8; Lipopolysaccharide; Pyrogens

Indexed keywords

BICARBONATE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; POLYETHER DERIVATIVE; SULFONE DERIVATIVE; TRITON X 100;

ARTICLE; ARTIFICIAL KIDNEY; ARTIFICIAL MEMBRANE; BACTERIUM CONTAMINATION; CHEMOLUMINESCENCE; CYTOKINE PRODUCTION; DEVICE; DIALYSATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIOLOGICAL TECHNIQUES; BLOOD DONORS; CHEMILUMINESCENT MEASUREMENTS; CYTOKINES; DIALYSIS SOLUTIONS; DRUG CONTAMINATION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; PLASTICS; POLYMERS; PSEUDOMONAS AERUGINOSA; RENAL DIALYSIS; SULFONES;

EID: 0031692697     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014336     Document Type: Article

References (22)

1. Bland LA, Favero MS: Microbiological aspects of hemodialysis systems; in: AAMI Standards and Recommended Practices. D Arlington, Association for the Advancement of Medical Instrumentation, 1995, vol 3, pp 257-265.
2. Bland LA, Favero MS, Arduino MJ: Should hemodialysis fluid be sterile? Semin Dial 1993;6:34-36.
3. Jaber BL, Pereira BJG: Dialysis reactions. Semin Dial 1997; 10:158-165.
4. Tokars JI, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA: National surveillance of dialysis associated diseases in the United States, 1992. ASAIO J 1994;40:1020-1031.
5. Ebben J, Jirsch D, Luehmann D: Microbiological contamination of liquid bicarbonate concentrate for hemodialysis. Trans Am Soc Artif Intern Organs 1987;33:269-273.
6. Man NK, Ciancioni C, Faivre JM, Diab N, London G, Maret J, Warmbergue FP: Dialysis-associated adverse reactions with high-flux membranes and microbial contamination of liquid bicarbonate concentrate; in de Broe ME, Kazatchkine M, Laurent G, Forêt M (eds): Bio-Incompatibility and Dialysis. Contrib Nephrol. Basel, Karger, 1988, vol 62, pp 24-34.
7. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995; 47:573-578.
8. Sundaram S, Barrett TW, Meyer KB, Perrella C, Cendoroglo MN, King AJ, Pereira BJG: Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers. J Am Soc Nephrol 1996;7:2183-2191.
9. Bland LA, Favero MS: Microbiologic and endotoxin considerations in hemodialyzer reprocessing: in: AAMI Standards and Recommended Practices. D Arlington, Association for the Advancement of Medical Instrumentation, 1995, vol 3, pp 293-300.
10. Lonnemann G: Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Kidney Int 1993;43(suppl):195-200.
11. Pereira BJG, Sundaram S, Barrett TW, Butt NK, Porat R, King AJ, Dinarello CA: Transfer of cytokine-inducing bacterial products across hemodialysis membranes: Role of bacterial species, plasma and whole blood. Clin Nephrol 1996;46:394-401.
12. Dinarello CA, Lonnemann G, Maxwell R, Shaldon S: Ultrafiltration to reject human interleukin-1 inducing substances derived from bacterial cultures. J Clin Microbiol 1987;25: 1233-1238.
13. Schindler R, Dinarello CA: A method for removing interleukin-1 and tumor necrosis factor inducing substances from bacterial cultures by ultrafiltration with polysulfone. J Immunol Methods 1989;116:159-165.
14. Sundaram S, Barrett TW, Butt NK, Porat R, King AJ, Pereira BJG: Cytokine production by human peripheral blood mononuclear cells stimulated by a Pseudomonas aeruginosa culture filtrate: Role of plasma and polymyxin B. Int J Artif Organs 1996;19:276-283.
15. Lonnemann G, Behme T, Lenzner B, Floege J, Schulze M, Colton CK, Koch KM, Shaldon S: Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Kidney Int 1992;42:61-68.
16. Puren AJ, Fantuzzi G, Gu Y, Su MS-S, Dinarello CA: Interleukin-18 (IFN-y-inducing factor) induces IL-Iβ and IL-8 via TNFα production from non-CD 14+ human mononuclear cells. J Clin Invest 1998;101: 711-724.
17. Colton CK: Analysis of membrane processes for blood purification. Blood Purif 1987;5:202-251.
18. Yamamoto C, Kim ST: Endotoxin rejection by ultrafiltration through high-flux, hollow-fiber filters. J Biomed Mater Res 1996;32:467-471.
19. Pereira BJG, Sundaram S, Snodgrass B, Hogan P, King AJ: Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients. J Am Soc Nephrol 1996;7: 479-487.
20. Tilg H, Pape D, Trehu E, Shapiro L, Atkins MB, Dinarello CA, Mier JW: A method for the detection of erythrocyte-bound interleukin-8 in humans during interleukin-1 immunotherapy. J Immunol Methods 1993; 163:253-258.
21. Engelman H, Novick D, Wallach D: Two tumor necrosis factor-binding proteins purified from human urine: Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 1990;265:1531-1536.
22. Borth W, Urbanski A, Prohaska R, Susanj M, Luger TA: Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune com-plexes. Blood 1990;75:2388-2395.